Search results
Results from the WOW.Com Content Network
ADAM17 is an 824-amino acid polypeptide.[5] [6]ADAM17 has multidomain structure that includes a pro-domain, a metallo-protease domain, a disintegrin domain, a cysteine-rich domain, an EGF-like domain, a transmembrane domain, and a cytoplasmic tail.
ADAM17 also has a role in the shedding of L-selectin, a cellular adhesion molecule. [16] ADAM18: The protein encoded by this gene is a sperm surface protein. [17] Synonymous with ADAM27. ADAM19: This member is a type I transmembrane protein and serves as a marker for dendritic cell differentiation. It has also been demonstrated to be an active ...
[36] [37] PAI-1 inhibits plasminogen activators and thus plasmin activation; therefore it could be assumed that PAI-1 deficiency would increase angiogenesis and tumor growth. Unexpectedly, when PAI-1 deficient mice were challenged with cancer cells on a collagenous matrix, angiogenesis and vascular stabilization was inhibited, hampering tumor ...
Tissue differentiation antigens are those that are specific to a certain type of tissue. Mutant protein antigens are likely to be much more specific to cancer cells because normal cells shouldn't contain these proteins. Normal cells will display the normal protein antigen on their MHC molecules, whereas cancer cells will display the mutant version.
Immune cells such as T-cells are usually isolated from patients for expansion or engineering purposes and reinfused back into patients to fight diseases using their own immune system. A major application of cellular adoptive therapy is cancer treatment, as the immune system plays a vital role in the development and growth of cancer. [1]
A 2020 study found that ADAM10 enhances the proliferation, migration, and invasion of osteosarcoma cells by modulating the E-cadherin/β-catenin signaling pathway, with miR-122-5p identified as a regulatory upstream target of ADAM10, suggesting that the miR-122-5p/ADAM10 axis may represent a potential therapeutic target for osteosarcoma.
Tumor stroma and extracellular matrix in hypoxia. Tumor hypoxia is the situation where tumor cells have been deprived of oxygen.As a tumor grows, it rapidly outgrows its blood supply, leaving portions of the tumor with regions where the oxygen concentration is significantly lower than in healthy tissues.
[12] [10] Major isoform of 17β-HSD in the granulosa cells of the ovaries. [13] Mutations and associated deficiency have not been reported in humans. [ 14 ] Knockout mice show altered ovarian sex steroid production, normal puberty, and severe subfertility due to defective luteinization and ovarian progesterone production.